MET and cancer: Therefore, combination of conventional anti‐cancer treatment with more specific interference with Met targeting to late endosomes, formation of specific signaling complexes on late endosomes or their activation from late endosomes might possibly be an alternative strategy in the future cancer therapies in addition to specific anti Met drugs being tested now on patients in clinical trials.